Financial Snapshot

Revenue
$258.0B
TTM
Gross Margin
84.5%
TTM
Net Earnings
$89.90B
TTM
Current Assets
$177.5B
Q2 2024
Current Liabilities
$187.9B
Q2 2024
Current Ratio
94.46%
Q2 2024
Total Assets
$369.4B
Q2 2024
Total Liabilities
$256.9B
Q2 2024
Book Value
$112.5B
Q2 2024
Cash
P/E
43.48
Nov 29, 2024 EST
Free Cash Flow
$66.03B
TTM

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Revenue $232.3B $177.0B $140.8B $126.9B $122.0B $111.8B $111.7B $111.8B $107.9B $88.81B $83.57B $78.03B $66.35B $60.78B $51.08B $45.55B $41.83B $38.74B $33.76B $29.03B $26.16B $24.87B $23.78B $20.81B $16.42B $13.65B $16.93B $14.87B $13.72B $13.52B $12.16B
YoY Change 31.26% 25.68% 10.91% 4.04% 9.11% 0.12% -0.08% 3.57% 21.53% 6.26% 7.11% 17.6% 9.16% 18.99% 12.13% 8.9% 7.97% 14.76% 16.29% 10.98% 5.2% 4.58% 14.25% 26.72% 20.34% -19.4% 13.84% 8.38% 1.47% 11.19%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Revenue $232.3B $177.0B $140.8B $126.9B $122.0B $111.8B $111.7B $111.8B $107.9B $88.81B $83.57B $78.03B $66.35B $60.78B $51.08B $45.55B $41.83B $38.74B $33.76B $29.03B $26.16B $24.87B $23.78B $20.81B $16.42B $13.65B $16.93B $14.87B $13.72B $13.52B $12.16B
Cost Of Revenue $35.77B $28.45B $23.66B $20.93B $19.56B $17.62B $17.63B $17.18B $16.19B $14.56B $14.14B $13.47B $12.59B $11.68B $10.44B $10.11B $9.793B $9.585B $9.177B $8.050B $7.409B $6.598B $5.979B $5.044B $4.227B $3.751B $5.771B $5.014B $4.972B $4.890B $4.333B
Gross Profit 196.5B dkks 148.5B dkks $117.1B $106.0B $102.5B $94.21B $94.06B $94.60B $91.74B $74.24B $69.43B $64.56B $53.76B $49.10B $40.64B $35.44B $32.04B $29.16B $24.58B $20.98B $18.75B $18.27B $17.80B $15.77B $12.20B $9.896B $11.16B $9.859B $8.751B $8.634B $7.830B
Gross Profit Margin 84.6% 83.92% 83.2% 83.51% 83.97% 84.25% 84.21% 84.63% 85.0% 83.6% 83.08% 82.74% 81.03% 80.78% 79.56% 77.81% 76.59% 75.26% 72.82% 72.27% 71.68% 73.47% 74.85% 75.76% 74.26% 72.51% 65.92% 66.29% 63.77% 63.84% 64.38%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Selling, General & Admin $60.77B $49.93B $40.41B $36.11B $35.30B $33.66B $32.38B $32.63B $32.69B $28.34B $28.44B $30.69B $27.59B $26.18B $22.58B $15.50B $14.88B $14.00B $11.81B $10.22B $9.308B $9.147B $9.080B $8.132B $6.533B $5.609B $6.087B $5.538B $4.927B $4.896B $4.449B
YoY Change 21.7% 23.57% 11.91% 2.29% 4.89% 3.93% -0.75% -0.19% 15.34% -0.32% -7.33% 11.24% 5.38% 15.91% 45.69% 4.18% 6.32% 18.47% 15.54% 9.84% 1.76% 0.74% 11.66% 24.48% 16.47% -7.85% 9.91% 12.4% 0.63% 10.05%
% of Gross Profit 30.93% 33.62% 34.5% 34.06% 34.45% 35.72% 34.43% 34.49% 35.63% 38.18% 40.96% 47.53% 51.32% 53.32% 55.57% 43.73% 46.44% 48.0% 48.05% 48.73% 49.65% 50.07% 51.02% 51.58% 53.57% 56.68% 54.54% 56.17% 56.3% 56.71% 56.82%
Research & Development 32.44B dkks 24.05B dkks $16.29B $13.71B $13.48B $13.57B $13.28B $13.64B $12.94B $12.85B $11.27B $6.136B $5.015B $5.445B $4.118B $7.531B $7.213B $6.316B $5.085B $4.352B $4.055B $3.952B $3.970B $3.390B $2.748B $2.795B $2.761B $2.244B $1.950B $1.896B $1.669B
YoY Change 34.91% 47.6% 18.81% 1.75% -0.67% 2.18% -2.68% 5.47% 0.7% 14.01% 83.62% 22.35% -7.9% 32.22% -45.32% 4.41% 14.2% 24.21% 16.84% 7.32% 2.61% -0.45% 17.11% 23.36% -1.68% 1.23% 23.04% 15.08% 2.85% 13.6%
% of Gross Profit 16.51% 16.19% 13.91% 12.94% 13.15% 14.4% 14.12% 14.42% 14.1% 17.3% 16.23% 9.5% 9.33% 11.09% 10.13% 21.25% 22.51% 21.66% 20.69% 20.74% 21.63% 21.63% 22.31% 21.5% 22.53% 28.24% 24.74% 22.76% 22.28% 21.96% 21.32%
Depreciation & Amortization $9.413B $7.362B $6.025B $5.753B $5.661B $3.925B $3.182B $3.193B $2.959B $3.435B $2.799B $2.693B $2.737B $2.467B $2.551B $2.442B $3.007B $2.142B $1.930B $1.892B $1.581B $1.293B $1.081B $1.038B $943.0M $986.0M $1.308B $1.223B $1.140B $1.055B $797.0M
YoY Change 27.86% 22.19% 4.73% 1.63% 44.23% 23.35% -0.34% 7.91% -13.86% 22.72% 3.94% -1.61% 10.94% -3.29% 4.46% -18.79% 40.38% 10.98% 2.01% 19.67% 22.27% 19.61% 4.14% 10.07% -4.36% -24.62% 6.95% 7.28% 8.06% 32.37%
% of Gross Profit 4.79% 4.96% 5.14% 5.43% 5.52% 4.17% 3.38% 3.38% 3.23% 4.63% 4.03% 4.17% 5.09% 5.02% 6.28% 6.89% 9.39% 7.35% 7.85% 9.02% 8.43% 7.08% 6.07% 6.58% 7.73% 9.96% 11.72% 12.4% 13.03% 12.22% 10.18%
Operating Expenses 32.44B dkks 24.05B dkks $57.78B $51.41B $48.78B $46.97B $44.79B $45.62B $44.78B $39.11B $37.80B $35.09B $31.38B $30.21B $25.71B $23.07B $23.10B $20.04B $16.50B $14.00B $12.33B $12.34B $12.18B $10.95B $8.319B $6.963B $8.120B $7.268B $6.496B $6.450B $5.892B
YoY Change 34.91% -58.38% 12.4% 5.4% 3.85% 4.88% -1.84% 1.88% 14.49% 3.49% 7.72% 11.8% 3.9% 17.5% 11.43% -0.11% 15.26% 21.49% 17.81% 13.58% -0.11% 1.3% 11.25% 31.64% 19.47% -14.25% 11.72% 11.88% 0.71% 9.47%
Operating Profit 164.1B dkks 124.5B dkks $59.36B $54.60B $53.68B $47.24B $49.28B $48.97B $46.96B $35.13B $31.64B $29.47B $22.37B $18.89B $14.93B $12.37B $8.942B $9.119B $8.088B $6.980B $6.422B $5.927B $5.614B $4.816B $3.877B $2.933B $3.041B $2.591B $2.255B $2.184B $1.938B
YoY Change 31.81% 109.68% 8.71% 1.71% 13.63% -4.13% 0.62% 4.29% 33.67% 11.04% 7.34% 31.73% 18.44% 26.51% 20.69% 38.37% -1.94% 12.75% 15.87% 8.69% 8.35% 5.58% 16.57% 24.22% 32.19% -3.55% 17.37% 14.9% 3.25% 12.69%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Interest Expense 542.0M dkks 378.0M dkks $558.0M -$846.0M -$3.757B $439.0M -$219.0M -$549.0M -$5.880B -$285.0M $1.127B -$360.0M -$248.0M $847.0M -$136.0M $374.0M $2.152B $375.0M $543.0M $532.0M $1.010B $445.0M $425.0M $24.00M -$178.0M $243.0M $257.0M $235.0M $78.00M -$118.0M -$72.00M
YoY Change 43.39% -32.26% -165.96% -77.48% -955.81% -300.46% -60.11% -90.66% 1963.16% -125.29% -413.06% 45.16% -129.28% -722.79% -136.36% -82.62% 473.87% -30.94% 2.07% -47.33% 126.97% 4.71% 1670.83% -113.48% -173.25% -5.45% 9.36% 201.28% -166.1% 63.89%
% of Operating Profit 0.33% 0.3% 0.94% -1.55% -7.0% 0.93% -0.44% -1.12% -12.52% -0.81% 3.56% -1.22% -1.11% 4.48% -0.91% 3.02% 24.07% 4.11% 6.71% 7.62% 15.73% 7.51% 7.57% 0.5% -4.59% 8.29% 8.45% 9.07% 3.46% -5.4% -3.72%
Other Income/Expense, Net -$197.0M -$181.0M -$122.0M -$150.0M -$173.0M -$72.00M -$68.00M -$85.00M -$81.00M -$111.0M -$81.00M -$1.303B -$201.0M -$1.452B -$809.0M -$52.00M -$123.0M -$330.0M -$397.0M -$55.00M -$56.00M -$44.00M -$9.000M
YoY Change 8.84% 48.36% -18.67% -13.29% 140.28% 5.88% -20.0% 4.94% -27.03% 37.04% -93.78% 548.26% -86.16% 79.48% 1455.77% -57.72% -62.73% -16.88% 621.82% -1.79% 27.27% 388.89%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

No data

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Pretax Income $104.7B $69.06B $59.08B $53.13B $48.55B $47.62B $48.68B $47.80B $43.48B $34.10B $32.54B $27.81B $21.93B $18.29B $13.99B $12.70B $10.97B $9.164B $8.234B $7.457B $7.376B $6.328B $6.030B $4.840B $3.349B $3.176B $3.298B $2.722B $2.156B $1.932B $1.866B
YoY Change 51.57% 16.9% 11.2% 9.43% 1.97% -2.19% 1.85% 9.92% 27.53% 4.79% 17.0% 26.85% 19.9% 30.73% 10.19% 15.71% 19.72% 11.29% 10.42% 1.1% 16.56% 4.94% 24.59% 44.52% 5.45% -3.7% 21.16% 26.25% 11.59% 3.54%
Income Tax $20.99B $13.54B $11.32B $10.99B $9.602B $8.987B $10.55B $9.873B $8.623B $7.615B $7.355B $6.379B $4.828B $3.883B $3.220B $3.050B $2.449B $2.712B $2.370B $2.444B $2.543B $2.212B $2.165B $1.753B $1.348B $1.160B $1.201B $966.0M $593.0M $500.0M $440.0M
% Of Pretax Income 20.05% 19.6% 19.17% 20.69% 19.78% 18.87% 21.67% 20.66% 19.83% 22.33% 22.6% 22.94% 22.02% 21.23% 23.02% 24.03% 22.32% 29.59% 28.78% 32.77% 34.48% 34.96% 35.9% 36.22% 40.25% 36.52% 36.42% 35.49% 27.5% 25.88% 23.58%
Net Earnings 83.68B dkks 55.53B dkks $47.76B $42.14B $38.95B $38.63B $38.13B $37.93B $34.86B $26.48B $25.18B $21.43B $17.10B $14.40B $10.77B $9.645B $8.522B $6.452B $5.864B $5.013B $4.833B $4.116B $3.865B $3.087B $2.001B $2.016B $2.097B $1.759B $1.563B $1.432B $1.426B
YoY Change 50.71% 16.27% 13.33% 8.18% 0.84% 1.31% 0.54% 8.79% 31.64% 5.15% 17.51% 25.36% 18.7% 33.76% 11.64% 13.18% 32.08% 10.03% 16.98% 3.72% 17.42% 6.49% 25.2% 54.27% -0.74% -3.86% 19.22% 12.54% 9.15% 0.42%
Net Earnings / Revenue 36.03% 31.38% 33.92% 33.19% 31.92% 34.54% 34.14% 33.93% 32.3% 29.82% 30.13% 27.47% 25.77% 23.7% 21.08% 21.17% 20.37% 16.65% 17.37% 17.27% 18.48% 16.55% 16.26% 14.83% 12.18% 14.77% 12.38% 11.83% 11.39% 10.59% 11.72%
Basic Earnings Per Share
Diluted Earnings Per Share $18.62 $24.44 $20.74M $18.01M $16.38M $15.93M $15.39M $14.96M $13.52M $5.03 $4.67 $3.88 $3.00 $2.46 $1.78 $1.55 $1.34 $1.00 $0.89 $0.74 $0.71 $0.59 $0.56 $0.44 $0.28 $0.27 $0.28 $0.23 $0.21 $0.19 $0.19

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

No data

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Cash & Short-Term Investments $29.37B $23.12B $16.36B $12.10B $14.97B $15.64B $18.85B $20.70B $20.47B $15.91B $14.47B $16.11B $17.50B $12.02B $11.30B $8.781B $4.823B $3.270B $3.303B $3.433B $1.262B $1.423B $1.660B $1.278B $1.270B $799.0M $1.120B $912.0M $1.503B $998.0M $794.0M
YoY Change 27.07% 41.28% 35.18% -19.12% -4.3% -17.05% -8.92% 1.14% 28.67% 9.92% -10.16% -7.98% 45.64% 6.38% 28.64% 82.07% 47.49% -1.0% -3.79% 172.03% -11.31% -14.28% 29.89% 0.63% 58.95% -28.66% 22.81% -39.32% 50.6% 25.69%
Cash & Equivalents
Short-Term Investments $15.84B $10.92B $6.765B $0.00 $2.009B $3.542B $1.509B $3.741B $4.552B $4.094B
Other Short-Term Assets $3.201B $3.185B $2.813B $2.985B $697.0M $2.257B $3.917B $2.113B $304.0M $1.252B $2.631B $1.964B $983.0M $4.651B $2.221B $1.970B $3.157B $2.668B $2.244B $1.799B $1.828B $315.0M $1.402B $2.567B $2.172B $1.918B $2.922B $1.888B $2.224B $3.067B $2.765B
YoY Change 0.5% 13.22% -5.76% 328.26% -69.12% -42.38% 85.38% 595.07% -75.72% -52.41% 33.96% 99.8% -78.86% 109.41% 12.74% -37.6% 18.33% 18.89% 24.74% -1.59% 480.32% -77.53% -45.38% 18.19% 13.24% -34.36% 54.77% -15.11% -27.49% 10.92%
Inventory $31.81B $24.39B $19.62B $18.54B $17.64B $16.34B $15.37B $14.34B $12.76B $11.36B $9.552B $9.543B $9.433B $9.689B $10.02B $9.611B $9.020B $8.400B $7.782B $7.163B $6.531B $5.919B $4.760B $3.972B $3.583B $4.642B $4.527B $2.505B $2.274B $2.480B $2.051B
Prepaid Expenses
Receivables $64.77B $50.56B $40.64B $27.73B $24.91B $22.79B $20.17B $20.23B $15.49B $13.04B $10.91B $9.639B $9.349B $8.500B $7.063B $6.581B $6.092B $5.163B $4.794B $4.062B $3.785B $3.811B $3.882B $3.396B $2.913B $3.401B $3.546B $3.454B $2.792B $2.748B $2.653B
Other Receivables $10.49B $6.945B $6.156B $4.450B $4.240B $2.050B $1.773B $2.379B $6.128B $4.738B $4.499B $2.912B $2.324B $2.436B $2.070B $2.121B $1.210B $1.334B $1.437B $1.292B $2.786B $2.304B $2.160B $1.642B $2.568B $2.304B $1.256B $2.205B $1.573B $1.295B $907.0M
Total Short-Term Assets $139.6B $108.2B $85.60B $65.81B $62.46B $59.07B $60.08B $59.77B $55.14B $46.29B $42.06B $40.16B $39.59B $37.29B $32.67B $29.06B $24.30B $20.84B $19.56B $17.75B $16.19B $13.77B $13.86B $12.86B $12.51B $13.06B $13.37B $10.96B $10.37B $10.59B $9.170B
YoY Change 29.07% 26.4% 30.07% 5.37% 5.74% -1.69% 0.53% 8.39% 19.11% 10.07% 4.72% 1.44% 6.16% 14.16% 12.39% 19.6% 16.64% 6.52% 10.2% 9.62% 17.57% -0.66% 7.85% 2.79% -4.27% -2.3% 21.95% 5.77% -2.1% 15.46%
Property, Plant & Equipment $90.96B $66.67B $55.36B $50.27B $50.55B $41.89B $35.25B $30.18B $25.55B $23.14B $21.88B $21.54B $20.93B $20.51B $19.23B $18.64B $19.61B $20.35B $19.94B $17.56B $16.34B $16.21B $13.63B $10.90B $10.19B $13.83B $13.22B $10.79B $10.13B $10.14B $9.596B
YoY Change 36.43% 20.43% 10.13% -0.56% 20.67% 18.85% 16.79% 18.14% 10.41% 5.73% 1.59% 2.9% 2.07% 6.66% 3.15% -4.93% -3.66% 2.05% 13.57% 7.45% 0.85% 18.93% 25.02% 6.97% -26.33% 4.62% 22.58% 6.44% -0.08% 5.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $981.0M $886.0M $1.078B $1.348B $1.444B $1.296B $1.195B $1.508B $2.150B $856.0M $551.0M $228.0M $273.0M $297.0M $358.0M $416.0M $631.0M $957.0M $1.095B $1.005B $1.081B $1.251B $1.401B $1.109B $227.0M $210.0M $189.0M $155.0M $122.0M $110.0M $112.0M
YoY Change 10.72% -17.81% -20.03% -6.65% 11.42% 8.45% -20.76% -29.86% 151.17% 55.35% 141.67% -16.48% -8.08% -17.04% -13.94% -34.07% -34.06% -12.6% 8.96% -7.03% -13.59% -10.71% 26.33% 388.55% 8.1% 11.11% 21.94% 27.05% 10.91% -1.79%
Other Assets $20.38B $13.43B $8.672B $5.865B $4.121B $2.893B $1.941B $2.683B $6.806B $5.399B $4.231B $2.244B $2.414B $1.847B $1.455B $1.696B $2.522B $1.911B $879.0M $769.0M $579.0M $110.0M $110.0M $110.0M $110.0M
YoY Change 51.78% 54.83% 47.86% 42.32% 42.45% 49.05% -27.66% -60.58% 26.06% 27.61% 88.55% -7.04% 30.7% 26.94% -14.21% -32.75% 31.97% 117.41% 14.3% 32.82% 0.0% 0.0% 0.0%
Total Long-Term Assets $174.8B $133.1B $108.9B $79.11B $63.16B $51.70B $42.28B $37.77B $36.66B $30.77B $28.28B $25.51B $25.11B $24.11B $22.08B $21.54B $23.43B $23.86B $22.40B $19.68B $18.37B $17.72B $15.04B $12.07B $10.58B $14.28B $13.80B $11.27B $10.52B $10.55B $10.01B
YoY Change 31.4% 22.17% 37.67% 25.27% 22.15% 22.3% 11.92% 3.04% 19.14% 8.81% 10.87% 1.59% 4.14% 9.21% 2.49% -8.07% -1.79% 6.5% 13.8% 7.14% 3.66% 17.84% 24.67% 14.08% -25.93% 3.46% 22.45% 7.14% -0.28% 5.43%
Total Assets $314.5B $241.3B $194.5B $144.9B $125.6B $110.8B $102.4B $97.54B $91.80B $77.06B $70.34B $65.67B $64.70B $61.40B $54.74B $50.60B $47.73B $44.69B $41.96B $37.43B $34.56B $31.50B $28.91B $24.92B $23.08B $27.34B $27.17B $22.23B $20.89B $21.14B $19.18B
YoY Change
Accounts Payable $25.61B $15.59B $8.870B $5.717B $6.358B $6.756B $5.610B $6.011B $4.927B $4.950B $4.092B $3.859B $3.291B $2.906B $2.242B $2.281B $1.947B $1.712B $1.500B $1.061B $1.008B $864.0M $970.0M $977.0M $807.0M $768.0M $579.0M $780.0M $872.0M $1.030B $924.0M
YoY Change 64.28% 75.73% 55.15% -10.08% -5.89% 20.43% -6.67% 22.0% -0.46% 20.97% 6.04% 17.26% 13.25% 29.62% -1.71% 17.15% 13.73% 14.13% 41.38% 5.26% 16.67% -10.93% -0.72% 21.07% 5.08% 32.64% -25.77% -10.55% -15.34% 11.47%
Accrued Expenses $600.0M $875.0M $590.0M $598.0M $478.0M $7.015B $6.799B $11.05B $11.28B $9.794B $8.527B $8.982B $8.534B $7.954B $2.147B $1.938B $1.817B $2.411B $2.350B $1.367B $859.0M $828.0M $813.0M $615.0M $478.0M
YoY Change -31.43% 48.31% -1.34% 25.1% -93.19% 3.18% -38.48% -2.04% 15.18% 14.86% -5.07% 5.25% 7.29% 10.78% 6.66% 2.6% 71.91% 59.14% 3.74% 1.85% 32.2% 28.66%
Deferred Revenue
YoY Change
Short-Term Debt $456.0M $480.0M $12.86B $6.684B $659.0M $515.0M $1.694B $229.0M $1.073B $720.0M $215.0M $548.0M $1.843B $1.720B $418.0M $1.334B $251.0M $326.0M $1.419B $470.0M $0.00 $574.0M $791.0M $811.0M $985.0M $0.00 $0.00 $0.00 $0.00 $9.000M $3.000M
YoY Change -5.0% -96.27% 92.43% 914.26% 27.96% -69.6% 639.74% -78.66% 49.03% 234.88% -60.77% -70.27% 7.15% 311.48% -68.67% 431.47% -23.01% -77.03% 201.91% -100.0% -27.43% -2.47% -17.66% -100.0% 200.0%
Long-Term Debt Due $6.022B $986.0M $822.0M $775.0M $815.0M $0.00 $154.0M $12.00M $25.00M $37.00M $975.0M $60.00M $42.00M $49.00M $47.00M $923.0M $1.336B $1.349B $1.451B $1.438B $954.0M
YoY Change 510.75% 19.95% 6.06% -4.91% -100.0% 1183.33% -52.0% -32.43% -96.21% 1525.0% 42.86% -14.29% 4.26% -94.91% -30.91% -0.96% -7.03% 0.9% 50.73%
Total Short-Term Liabilities $169.7B $120.9B $99.52B $70.27B $58.98B $54.16B $47.06B $47.44B $40.87B $33.69B $24.23B $21.64B $20.78B $18.48B $13.42B $12.96B $10.64B $10.16B $10.58B $7.280B $7.032B $5.969B $6.006B $5.496B $5.632B $5.486B $5.298B $4.897B $4.665B $4.581B $3.679B
YoY Change 40.28% 21.53% 41.61% 19.14% 8.9% 15.11% -0.8% 16.06% 21.32% 39.07% 11.96% 4.13% 12.46% 37.73% 3.53% 21.77% 4.77% -4.01% 45.34% 3.53% 17.81% -0.62% 9.28% -2.41% 2.66% 3.55% 8.19% 4.97% 1.83% 24.52%
Long-Term Debt $20.53B $24.32B $12.96B $2.897B $3.009B $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $502.0M $504.0M $970.0M $980.0M $961.0M $1.174B $1.248B $1.188B $753.0M $824.0M $863.0M $950.0M $1.007B $1.835B $1.758B $944.0M $1.322B $3.109B $3.333B
YoY Change -15.59% 87.62% 347.39% -3.72% -100.0% -0.4% -48.04% -1.02% 1.98% -18.14% -5.93% 5.05% 57.77% -8.62% -4.52% -9.16% -5.66% -45.12% 4.38% 86.23% -28.59% -57.48% -6.72%
Other Long-Term Liabilities $11.37B $7.828B $6.014B $5.925B $5.947B $4.648B $4.638B $4.821B $3.951B $3.072B $2.871B $2.667B $2.763B $2.592B $1.613B $1.282B $1.601B $1.241B $651.0M $608.0M $493.0M $653.0M $541.0M $523.0M $456.0M $430.0M $433.0M $403.0M $467.0M $310.0M $249.0M
YoY Change 45.2% 30.16% 1.5% -0.37% 27.95% 0.22% -3.8% 22.02% 28.61% 7.0% 7.65% -3.47% 6.6% 60.69% 25.82% -19.93% 29.01% 90.63% 7.07% 23.33% -24.5% 20.7% 3.44% 14.69% 6.05% -0.69% 7.44% -13.7% 50.65% 24.5%
Total Long-Term Liabilities $31.89B $32.15B $18.98B $8.822B $8.956B $4.648B $4.638B $4.821B $3.951B $3.072B $2.871B $2.667B $3.265B $3.096B $2.583B $2.262B $2.562B $2.415B $1.899B $1.796B $1.246B $1.477B $1.404B $1.473B $1.463B $2.265B $2.191B $1.347B $1.789B $3.419B $3.582B
YoY Change -0.78% 69.41% 115.09% -1.5% 92.69% 0.22% -3.8% 22.02% 28.61% 7.0% 7.65% -18.32% 5.46% 19.86% 14.19% -11.71% 6.09% 27.17% 5.73% 44.14% -15.64% 5.2% -4.68% 0.68% -35.41% 3.38% 62.66% -24.71% -47.67% -4.55%
Total Liabilities $207.9B $157.8B $123.8B $81.60B $68.02B $58.93B $52.54B $52.27B $44.83B $36.77B $27.77B $25.04B $27.25B $24.44B $19.01B $17.62B $15.55B $14.57B $14.33B $10.93B $9.788B $8.568B $8.768B $7.939B $7.897B $9.370B $8.931B $6.252B $6.465B $8.001B $7.262B
YoY Change 31.79% 27.48% 51.67% 19.96% 15.42% 12.16% 0.52% 16.6% 21.93% 32.41% 10.91% -8.12% 11.51% 28.56% 7.85% 13.34% 6.72% 1.7% 31.08% 11.66% 14.24% -2.28% 10.44% 0.53% -15.72% 4.92% 42.85% -3.29% -19.2% 10.18%

Ownership

Basic Shares Outstanding

No data

Diluted Shares Outstanding

No data

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $3.9089 Trillion

About NOVO NORDISK A S

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The firm's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The firm's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The firm also offers Saxenda product to treat obesity. The company offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Industry: Pharmaceutical Preparations Peers: